Filing Details

Accession Number:
0001104659-22-076049
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-30 08:30:22
Reporting Period:
2022-06-28
Accepted Time:
2022-06-30 08:30:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1875558 Nuvectis Pharma Inc. NVCT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1251213 Ron Bentsur C/O Nuvectis Pharma, Inc.,
1 Bridge Plaza, Suite 275
Fort Lee NJ 07024
Chairman & Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-06-28 300 $11.82 2,964,614 No 4 P Direct
Common Stock Acquisiton 2022-06-29 3,700 $11.62 2,968,314 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Includes 96,759 shares of restricted stock and 120,000 restricted stock units.
  2. Reflects the weighted average purchase price. The range of prices for the shares purchased was $11.60 to $11.70. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.